Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in State of Palestine

State of Palestine: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.0% in 2024. ◆ Volatile

Latest (2024)
0.0%
World rank
167th
of 246 countries
All-time high
0.1%
in 2015
All-time low
0.0%
in 2017
Years of data
10
2015–2024

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in State of Palestine, 2015–2024

00.020.040.060.080.12015201920242015: 0.1 %2016: 0.1 %2017: 0 %2018: 0 %2019: 0 %2020: 0 %2021: 0 %2022: 0 %2023: 0 %2024: 0 %

Source: United Nations Statistics Division, SDG Global Database. Measured in %.

Analysis

The most recent figure for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in State of Palestine is 0.0%, measured in 2024. That is the lowest value across all 10 years on record.

The figure is down 100.0% over ten years.

Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in State of Palestine peaked at 0.1% in 2015 and was at its lowest, 0.0%, in 2017.

State of Palestine ranks 167th of 246 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in State of Palestine, year by year

Annual values for Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%) in State of Palestine, 2015 to 2024.
Year % Change
2015 0.1%
2016 0.1% +0.0%
2017 0.0% -100.0%
2018 0.0%
2019 0.0%
2020 0.0%
2021 0.0%
2022 0.0%
2023 0.0%
2024 0.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 0.0% 0.0% 0.1% 5
2020s 0.0% 0.0% 0.0% 5

Countries ranked near State of Palestine

  1. 167 Andorra 0.0%
  2. 167 Argentina 0.0%
  3. 167 Austria 0.0%
  4. 167 Bahrain 0.0%
  5. 167 Belarus 0.0%
  6. 167 Belgium 0.0%
  7. 167 Bermuda 0.0%
  8. 167 Brazil 0.0%
  9. 167 Bulgaria 0.0% compare
  10. 167 Canada 0.0%
  11. 167 Chile 0.0%
  12. 167 Colombia 0.0%
  13. 167 Cook Islands 0.0%
  14. 167 Costa Rica 0.0%
  15. 167 Croatia 0.0%
  16. 167 Cuba 0.0%
  17. 167 Czechia 0.0%
  18. 167 Ecuador 0.0%
  19. 167 Egypt 0.0% compare
  20. 167 El Salvador 0.0%
  21. 167 Estonia 0.0%
  22. 167 Falkland Islands (Malvinas) 0.0%
  23. 167 Faroe Islands 0.0% compare
  24. 167 Finland 0.0%
  25. 167 France 0.0%
  26. 167 French Guiana 0.0%
  27. 167 French Polynesia 0.0% compare
  28. 167 Georgia 0.0%
  29. 167 Germany 0.0%
  30. 167 Gibraltar 0.0%
  31. 167 Greece 0.0%
  32. 167 Greenland 0.0%
  33. 167 Guatemala 0.0% compare
  34. 167 Guernsey 0.0% compare
  35. 167 Holy See 0.0%
  36. 167 Honduras 0.0%
  37. 167 Iceland 0.0% compare
  38. 167 Iran (Islamic Republic of) 0.0%
  39. 167 Ireland 0.0%
  40. 167 Isle of Man 0.0% compare
  41. 167 Italy 0.0%
  42. 167 Japan 0.0% compare
  43. 167 Jersey 0.0% compare
  44. 167 Kuwait 0.0%
  45. 167 Latvia 0.0% compare
  46. 167 Liechtenstein 0.0%
  47. 167 Luxembourg 0.0%
  48. 167 Malta 0.0% compare
  49. 167 Mexico 0.0%
  50. 167 Monaco 0.0%
  51. 167 Montenegro 0.0%
  52. 167 Morocco 0.0%
  53. 167 Netherlands (Kingdom of the) 0.0%
  54. 167 New Zealand 0.0% compare
  55. 167 Nicaragua 0.0% compare
  56. 167 Niue 0.0%
  57. 167 Norway 0.0% compare
  58. 167 Panama 0.0%
  59. 167 Poland 0.0%
  60. 167 Portugal 0.0%
  61. 167 Qatar 0.0% compare
  62. 167 Republic of Korea 0.0% compare
  63. 167 Saint Pierre and Miquelon 0.0%
  64. 167 San Marino 0.0%
  65. 167 Saudi Arabia 0.0%
  66. 167 Slovakia 0.0%
  67. 167 Slovenia 0.0% compare
  68. 167 Spain 0.0%
  69. 167 Sweden 0.0%
  70. 167 Switzerland 0.0% compare
  71. 167 Tokelau 0.0%
  72. 167 Türkiye 0.0% compare
  73. 167 United Arab Emirates 0.0%
  74. 167 United Kingdom of Great Britain and Northern Ireland 0.0% compare
  75. 167 Uruguay 0.0%
  76. 167 Republic of Korea 0.0% compare
  77. 167 Türkiye 0.0% compare
  78. 167 United Kingdom of Great Britain and Northern Ireland 0.0% compare
  79. 167 United States of America 0.0%

See the full ranking of 250 places →

More development goals data for State of Palestine

All data for State of Palestine →

Frequently asked questions

What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in State of Palestine?
Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in State of Palestine was 0.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in State of Palestine?
The highest recorded value was 0.1% in 2015.
What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in State of Palestine?
The lowest recorded value was 0.0% in 2017.
How does State of Palestine rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
State of Palestine ranks 167th out of 246 countries with data for 2024.
Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in State of Palestine?
Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
Where does this State of Palestine data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in State of Palestine. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 05 September 2026, from https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/state-of-palestine/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/state-of-palestine/">Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in State of Palestine</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed